4-Bromo-6-(trifluoromethyl)-1H-indazole

Catalog No.: 
ACJWEG829
CAS No.: 
1000342-95-9
Molecular Formula: 
C8H4BrF3N2
Molecular Weight: 
265.03
4-Bromo-6-(trifluoromethyl)-1H-indazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$170.00In stockIn stock
25g97%$816.00In stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-6-(trifluoromethyl)-1H-indazole
IUPAC Name4-bromo-6-(trifluoromethyl)-1H-indazole
MDL No.MFCD09026956
Molecular FormulaC8H4BrF3N2
Molecular Weight265.03
SMILESFC(F)(F)C1=CC(Br)=C2C=NNC2=C1
InChI KeyJRUCLQINUHVRJW-UHFFFAOYSA-N
Synonym4-Bromo-6-(trifluoromethyl)-1H-indazole | 1000342-95-9 | 4-Bromo-6-trifluoromethyl-indazole | 4-Bromo-6-trifluoromethyl-1H-indazole | MFCD09026956 | 1H-Indazole, 4-bromo-6-(trifluoromethyl)- | 6-(Trifluoromethyl)-4-bromo indazole | SCHEMBL14723382 | AMY7350 | DTXSID4064664
CAS No.1000342-95-9
PubChem CID24729232

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJWEG829 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJWEG829 route product structure diagram
    ACJWEG8291000342-95-9In Stock
Inquiry

2. ACJWEG829 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJWEG829 route product structure diagram
    ACJWEG8291000342-95-9In Stock
Inquiry

3. ACJWEG829 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJWEG829 route product structure diagram
    ACJWEG8291000342-95-9In Stock
Inquiry

Comments (0)